Healthcare
Live Price
Offline$44.77
-2.33% today
1Y Change
-7.68%
Window
Jun 30, 2025 → Jun 18, 2026
Coverage: 244 bars · Jun 30, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Chugai Pharmaceutical Co., Ltd. (CHGCF) is a Healthcare stock with a market cap of $13.57T and listed on OTC. The stock last traded around $44.77 and down 7.7% across the available one-year price window (Jun 30, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +7.6%, EPS growth of +12.2%, a dividend yield of 3.3%. What stands out right now is revenue +7.6%, EPS +12.2%, free cash flow -20.2% with operating margin 47.6% and ROIC 23.0%. The dividend matters to the case here, with a current yield around 3.3%. Valuation already assumes a fairly strong business story at P/E 30.0 and price/sales 10.5. Stock Foundry combines CHGCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
CHGCF is 28.54 pts behind over the shared 1Y window.
CHGCF had 24.65 pts deeper max drawdown than SPY.
CHGCF beat SPY in 0 of 2 calendar years shown and trailed in 2.
CHGCF
-7.68%
Normalized return
SPY
+20.86%
S&P 500
Excess Return
-28.54 pts
Relative to SPY
CHGCF Max Drawdown
-33.78%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for CHGCF and SPY.
| Year | CHGCF | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -12.48% | +6.71% | -19.19 pts | SPY |
| 2025 | +7.09% | +11.19% | -4.11 pts | SPY |
Unable to load analyst forecasts.
Timed out loading forecasts for CHGCF
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.